Simple dosing protocols, expected results, and everything you need to know about the 17 most popular peptides — all in one instant-download PDF guide.
The Only Peptide Guide You'll Ever Need
Simple dosing protocols, expected results, and everything you need to know about the 17 most popular peptides — all in one instant-download PDF guide.
The Only Peptide Guide You'll Ever Need
Everything you need to know about 17 of the most popular peptides, broken down into simple, actionable profiles.
BPC-157, Semaglutide, Tirzepatide, CJC-1295 and 13 more.
Clear guidelines for each peptide. Know exactly what to take and when.
Potential risks, contraindications, and what to watch for.
Realistic timelines so you know what to expect at every stage.
It's a comprehensive 23-page PDF guide covering the 17 most popular peptides used today. Each peptide profile includes what it does, dosing protocols, expected results and timelines, side effects, and stacking recommendations — all written in plain English.
The Peptide Bible is a digital PDF. After completing your purchase, you'll receive an instant download link on the order confirmation page and via email. You can save it to any device and access it anytime — no shipping required.
Whether you're brand new to peptides or already experienced, this guide has something for you. Beginners get a clear starting point with plain-English explanations, while experienced users benefit from detailed dosing protocols, stacking strategies, and side effect profiles for all 17 peptides.
No. The Peptide Bible is an educational reference guide only. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any peptide protocol.
The guide covers 17 peptides including BPC-157, TB-500, CJC-1295, Ipamorelin, MK-677, Semaglutide, Tirzepatide, PT-141, Melanotan II, GHK-Cu, Thymosin Alpha-1, Selank, Semax, DSIP, Epithalon, AOD-9604, and SS-31. Each one gets a full profile with dosing, results, side effects, and stacking info.